Trial Profile
A multicentre, observational study of palivizumab in infants With bronchopulmonary dysplasia (BPD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Palivizumab (Primary)
- Indications Bronchopulmonary dysplasia
- Focus Therapeutic Use
- 13 Dec 2015 New trial record